Optical coherence tomography angiography in preclinical neuroimaging
- Authors
- Choi, W.J.
- Issue Date
- Aug-2019
- Publisher
- Springer Verlag
- Keywords
- Angiography; Optical coherence tomography; Preclinical neuroimaging, small animal models; Traumatic brain injury, stroke, aging
- Citation
- Biomedical Engineering Letters, v.9, no.3, pp 311 - 325
- Pages
- 15
- Journal Title
- Biomedical Engineering Letters
- Volume
- 9
- Number
- 3
- Start Page
- 311
- End Page
- 325
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/33094
- DOI
- 10.1007/s13534-019-00118-8
- ISSN
- 2093-9868
2093-985X
- Abstract
- Preclinical neuroimaging allows for the assessment of brain anatomy, connectivity, and function in laboratory animals, such as mice and this imaging field has been a rapidly growing aimed at bridging the translation gap between animal and human research. The progress in the animal research could be accelerated by high-resolution in vivo optical imaging technologies. Optical coherence tomography-based angiography (OCTA) estimates the scattering from moving red blood cells, providing the visualization of functional micro-vessel networks within tissue beds in vivo without a need for exogenous contrast agents. Recent advancement of OCTA methods have expanded its application to neuroimaging of small animal models of brain disorders. In this paper, we overview the recent development of OCTA techniques for blood flow imaging and its preclinical applications in neuroimaging. In specific, a summary of preclinical OCTA studies for traumatic brain injury, cerebral stroke, and aging brain on mice is reviewed. © 2019, Korean Society of Medical and Biological Engineering.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of ICT Engineering > School of Electrical and Electronics Engineering > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/33094)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.